Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: February 7, 2017
Reporting Period: Quarter and nine months ended December 31, 2016
Context: The registrant is furnishing results of operations and financial condition previously announced via press release on February 4, 2017. Results are reported under International Financial Reporting Standards (IFRS) and Indian Accounting Standards (Ind AS).
Key Financial Metrics
The provided filing text serves as a cover document referencing attached exhibits for detailed financial data. It does not contain specific numerical values for the following metrics:
- Revenue
- Profit
- Cash Flow
- Margins
- Debt
- Liquidity
Note: The filing text does not provide a clear value for these metrics; they are contained in the attached Exhibits 99.1, 99.2, and 99.3.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It only confirms the announcement of results for the quarter and nine months ended December 31, 2016.
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are referenced as being available in the attached press release (Exhibit 99.1) and financial results documents (Exhibits 99.2 and 99.3).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, profit, and margin figures for Q3 and 9M FY17.
- Examine Exhibits 99.2 and 99.3 for Ind AS Unaudited Standalone and Consolidated Financial Results.
- Verify the reconciliation between IFRS and Ind AS reporting standards if discrepancies exist.
- Check the company website (www.drreddys.com) for the full text of the review reports attached to the financial results.